ANI Pharmaceuticals (ANIP) CFO Stephen P. Carey Sells 2,850 Shares

What Happened
Stephen P. Carey, SVP and Chief Financial Officer of ANI Pharmaceuticals (ANIP), sold 2,850 shares on 2026-08-31 in an open-market transaction. The sales had a weighted average price of $72.80 per share, totaling approximately $207,480. This was a sale (not a purchase); such sales are often routine and do not by themselves signal a change in company outlook.

Key Details

• Transaction date: 2026-08-31 (Form 4 filed 2026-09-01).
• Price(s): multiple trades at $71.89 to $73.36; weighted average reported $72.80.
• Shares sold: 2,850; Proceeds: ~$207,480.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes: sales were effected under a Rule 10b5-1 trading plan adopted by Carey on March 6, 2026; multiple trades produced the price range above.
• Filing timeliness: filed one day after the trade; Form 4 is typically due within two business days, so this filing does not appear late.

Context
The sale was carried out under a pre-arranged Rule 10b5-1 plan, which allows insiders to sell shares according to a preset schedule and reduces the implication that the trade reflects immediate insider knowledge. For retail investors, purchases tend to be more informative about insider sentiment; routine sales like this are common for liquidity or diversification and do not necessarily indicate a change in confidence.